Hjem › Hjertesvigt › Oklahoma
Hjertesvigt kliniske forsøg i Oklahoma
17 studier for Hjertesvigt søger deltagere på steder i Oklahoma.
Byer i Oklahoma
Officiel studietekst (engelsk)
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
- Oklahoma Heart Institute, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT03523416A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 1. okt. 2026 · NCT07214376A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Oklahoma City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Oklahoma State University Center for Health Sciences, Tulsa
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 24. sep. 2026 · NCT06736574Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- South Oklahoma Heart Research, Oklahoma City
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 16. sep. 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Oklahoma City
- Research Site, Oklahoma City
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Bartlesville, OK Investigative Site 10095, Bartlesville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06008197Pedal Pump Clinical Trial on Edema V2
- Hillcrest Medical Center, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07809516NORM-HF Pivotal Study
- Saint Francis Health System, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07574593Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Oklahoma Cardiovascular Research Group, Oklahoma City
Rekrutterer
Alder 21 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT05677100Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Oklahoma City
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 20. aug. 2026 · NCT00271180Alleviant ALLAY-HF Study
- South Oklahoma Heart Research, LLC., Oklahoma City
Rekrutterer
Alder 40 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT05685303Pedal Pump Clinical Trial on Edema V1
- Hillcrest Medical Center, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT07760363Assessment of CCM in HF With Higher Ejection Fraction
- Oklahoma Heart Institute, Tulsa
- St. Francis Hospital - Tulsa, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT05064709Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
- Saint Francis Hospital, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT06552637Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT03142152Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.